Sample journey
Here's what we found, Kailani
Your stool sample shows elevated calprotectin (185 µg/g) — a marker of inflammation in your gut. Combined with your 6-week symptom log, this pattern is more consistent with inflammatory bowel activity than with IBS alone. Microbiome diversity is on the low end of normal, and no pathogens were detected.
Most likely
Based on results + 6-week log
Probability estimates — not a diagnosis. Confirmation needs a gastroenterologist and follow-up workup.
A protein released by white blood cells when your gut lining is inflamed. Your level is meaningfully above the IBS cutoff, which is the single strongest data point in this report.
Lower diversity can follow antibiotic use, restrictive diets, or chronic inflammation. Not diagnostic on its own, but supports the inflammation picture.
No active infection detected — your symptoms are not being driven by an acute pathogen.
Treatments you may respond well to
Predicted from your inflammation profile, microbiome signature, and symptom pattern.
First-line for mild-moderate inflammatory activity. Good fit given calprotectin range.
Reduces symptom burden while workup is pending — does not treat inflammation.
May support diversity recovery alongside primary treatment.
Reserved if colonoscopy confirms moderate-severe IBD. Not indicated yet.
Doctor's 1-pager ready
A clinician-grade summary with ICD-10 references, calprotectin trend, symptom heatmap, and suggested workup (CBC, CRP, ferritin, colonoscopy criteria). Built to print or hand off in under 60 seconds.
ProGI provides decision support, not a diagnosis. Always confirm findings with a licensed clinician before starting, stopping, or changing any treatment.